Incidence and result of treatment-demanding retinopathy of prematurity using revised U.S. screening guidelines

American Journal of Perinatology

Volumn 29, Issue 10, 2012, Pages 827-831

  Kuo, Hsi Kung ^a   Chen, Chih Cheng ^a   Chen, Yi Hao ^a   Huang, Hsin Chun ^a   Liu, Chieh An ^a   Chen, Feng Shun ^a   Chung, Mei Yung ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

birth body weight; gestational age; retinopathy of prematurity; screening programs and criteria

Indexed keywords

BEVACIZUMAB;

ARTICLE; FEMALE; FOLLOW UP; GESTATIONAL AGE; HEALTH CARE QUALITY; HUMAN; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OUTPATIENT; PATIENT CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; RETROLENTAL FIBROPLASIA; SCREENING; TREATMENT OUTCOME; UNITED STATES;

ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL, HUMANIZED; BIRTH WEIGHT; EARLY MEDICAL INTERVENTION; FEMALE; GESTATIONAL AGE; HOSPITALIZATION; HUMANS; INCIDENCE; INFANT, NEWBORN; INFANT, PREMATURE; INTRAVITREAL INJECTIONS; MALE; MEDICAL RECORDS, PROBLEM-ORIENTED; MULTICENTER STUDIES AS TOPIC; NEONATAL SCREENING; PATIENT SELECTION; PRACTICE GUIDELINES AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RETINOPATHY OF PREMATURITY; SEVERITY OF ILLNESS INDEX; TAIWAN; TIME FACTORS; TREATMENT OUTCOME;

EID: 84867841880     PISSN: 07351631     EISSN: 10988785     Source Type: Journal    
DOI: 10.1055/s-0032-1321495     Document Type: Article

References (27)

1. Gilbert C., Fielder A., Gordillo L., et al. International NO-ROP Group Characteristics of infants with severe retinopathy of prematurity in countries with low, moderate, and high levels of development: implications for screening programs. Pediatrics: 2005; 115 e518 e525 (Pubitemid 43843209)
2. Azad R., Chandra P., Patwardhan S. D., Gupta A. Importance of the "third criteriono" for retinopathy of prematurity screening in developing countries. J Pediatr Ophthalmol Strabismus: 2009; 46 332 334; quiz 335-336
3. Başmak H., Niyaz L., Sahin A., Erol N., Gürsoy H. H. Retinopathy of prematurity: screening guidelines need to be reevaluated for developing countries. Eur J Ophthalmol: 2010; 20 752 755
4. Section on Ophthalmology American Academy of Pediatrics; American Academy of Ophthalmology; American Association for Pediatric Ophthalmology and Strabismus. Screening examination of premature infants for retinopathy of prematurity. Pediatrics: 2006; 117 572 576
5. Retinopathy of prematurity: guidelines for screening and treatment. The report of a Joint Working Party of The Royal College of Ophthalmologists and the British Association of Perinatal Medicine. Early Hum Dev: 1996; 46 239 258
6. Ugurbas S. C., Gulcan H., Canan H., Ankarali H., Torer B., Akova Y. A. Comparison of UK and US screening criteria for detection of retinopathy of prematurity in a developing nation. J AAPOS: 2010; 14 506 510
7. Yang M. B., Donovan E. F. Risk analysis and an alternative protocol for reduction of screening for retinopathy of prematurity. J AAPOS: 2009; 13 539 545
8. Zin A. A., Moreira M. EL, Bunce C., Darlow B. A., Gilbert C. E. Retinopathy of prematurity in 7 neonatal units in Rio de Janeiro: screening criteria and workload implications. Pediatrics: 2010; 126 e410 e417
9. Slidsborg C., Forman J. L., Rasmussen S., et al. A new risk-based screening criterion for treatment-demanding retinopathy of prematurity in Denmark. Pediatrics: 2011; 127 e598 e606
10. Cryotherapy for Retinopathy of Prematurity Cooperative Group Multicenter trial of cryotherapy for retinopathy of prematurity. Preliminary results. Arch Ophthalmol: 1988; 106 471 479
11. Early Treatment For Retinopathy Of Prematurity Cooperative Group Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial. Arch Ophthalmol: 2003; 121 1684 1694
12. Screening examination of premature infants for retinopathy of prematurity. A joint statement of the American Academy of Pediatric, the American Association for Pediatric Ophthalmology and Strabismus, and the American Academy of Ophthalmology. Ophthalmology: 1997; 104 888 889
13. American Academy of Pediatrics. Section on Ophthalmology. Screening examination of premature infants for retinopathy of prematurity. Pediatrics: 2001; 108 809 811
14. International Committee for the Classification of Retinopathy of Prematurity. The International Classification of Retinopathy of Prematurity revisited. Arch Ophthalmol: 2005; 123 991 999
15. Wu W. C., Yeh P. T., Chen S. N., Yang C. M., Lai C. C., Kuo H. K. Effects and complications of bevacizumab use in patients with retinopathy of prematurity: a multicenter study in Taiwan. Ophthalmology: 2011; 118 176 183
16. Cryotherapy for Retinopathy of Prematurity Cooperative Group Multicenter Trial of Cryotherapy for Retinopathy of Prematurity: ophthalmological outcomes at 10 years. Arch Ophthalmol: 2001; 119 1110 1118
17. Good W. V., Hardy R. J., Dobson V., et al. Early Treatment for Retinopathy of Prematurity Cooperative Group Final visual acuity results in the early treatment for retinopathy of prematurity study. Arch Ophthalmol: 2010; 128 663 671
18. Mantagos I. S., Vanderveen D. K., Smith L. EH. Emerging treatments for retinopathy of prematurity. Semin Ophthalmol: 2009; 24 82 86
19. Chen J., Stahl A., Hellstrom A., Smith L. E. Current update on retinopathy of prematurity: screening and treatment. Curr Opin Pediatr: 2011; 23 173 178
20. Mintz-Hittner H. A., Kuffel R. R. Jr. Intravitreal injection of bevacizumab (Avastin) for treatment of stage 3 retinopathy of prematurity in zone I or posterior zone II. Retina: 2008; 28 831 838
21. Mintz-Hittner H. A., Kennedy K. A., Chuang A. Z.; BEAT-ROP Cooperative Group. Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity. N Engl J Med: 2011; 364 603 615
22. Moshfeghi D. M., Berrocal A. M. Retinopathy of prematurity in the time of bevacizumab: incorporating the BEAT-ROP results into clinical practice. Ophthalmology: 2011; 118 1227 1228
23. Raizada S., Kandari J. A., Sabti K. A. Will the BEAT-ROP study results really beat ROP? Invest Ophthalmol Vis Sci: 2011; 52 9288 9289
24. Hiraoka M., Berinstein D. M., Trese M. T., Shastry B. S. Insertion and deletion mutations in the dinucleotide repeat region of the Norrie disease gene in patients with advanced retinopathy of prematurity. J Hum Genet: 2001; 46 178 181 (Pubitemid 32435599)
25. Ells A., Guernsey D. L., Wallace K., et al. Severe retinopathy of prematurity associated with FZD4 mutations. Ophthalmic Genet: 2010; 31 37 43
26. Shastry B. S. Genetic susceptibility to advanced retinopathy of prematurity (ROP). J Biomed Sci: 2010; 17 69
27. Fang P. C., Kuo H. K., Ko T. Y., Chen C. C., Hwang K. P., Chung M. Y. Retinopathy of prematurity in larger preterm infants. Am J Perinatol: 2006; 23 273 277